|
|
Volumn 190, Issue 2, 2007, Pages 265-268
|
|
CNS drugs approved by the centralised European procedure: True innovation or dangerous stagnation?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARIPIPRAZOLE;
CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA;
CENTRAL NERVOUS SYSTEM AGENTS;
DOPA DECARBOXYLASE INHIBITOR;
DOPAMINE RECEPTOR STIMULATING AGENT;
DULOXETINE;
ENTACAPONE;
ETIRACETAM;
HALOPERIDOL;
LEVODOPA;
MEMANTINE;
OLANZAPINE;
PLACEBO;
PRAMIPEXOLE;
PREGABALIN;
RASAGILINE;
RIVASTIGMINE;
TOLCAPONE;
VALPROIC ACID;
ZALEPLON;
ZONISAMIDE;
ADD ON THERAPY;
AGGRESSION;
ALZHEIMER DISEASE;
AMINOTRANSFERASE BLOOD LEVEL;
ANOREXIA;
BEHAVIOR DISORDER;
BIPOLAR DISORDER;
BODY TEMPERATURE;
BODY TEMPERATURE DISORDER;
BRADYCARDIA;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
CONFUSION;
CONVULSION;
DRUG APPROVAL;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG FATALITY;
DRUG MARKETING;
DRUG MEGADOSE;
DRUG SUBSTITUTION;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
ERYTHEMA;
EUROPE;
FALLING;
FOCAL EPILEPSY;
GAIT;
GOVERNMENT REGULATION;
HOSTILITY;
HUMAN;
HUNGER;
HYPERGLYCEMIA;
HYPOTENSION;
INSOMNIA;
LETHARGY;
LIBIDO;
LIVER TOXICITY;
MAINTENANCE DRUG DOSE;
MAJOR DEPRESSION;
MANIA;
MENTAL DISEASE;
MULTIINFARCT DEMENTIA;
NEUROLEPTIC MALIGNANT SYNDROME;
NOTE;
OPPOSITIONAL BEHAVIOR;
PARKINSON DISEASE;
PATHOLOGICAL GAMBLING;
PRIAPISM;
PRIORITY JOURNAL;
RELAPSE;
RESPIRATION DEPRESSION;
RHABDOMYOLYSIS;
SCHIZOPHRENIA;
SIDE EFFECT;
SLEEP DISORDER;
SLEEP TIME;
SOMNOLENCE;
SUDDEN SLEEP ONSET;
SUICIDAL IDEATION;
SUICIDE ATTEMPT;
TEMPERATURE REGULATION DISORDER;
VENOUS THROMBOEMBOLISM;
VISUAL HALLUCINATION;
WEIGHT REDUCTION;
CLINICAL TRIALS;
DIFFUSION OF INNOVATION;
DRUG APPROVAL;
DRUG TOXICITY;
EUROPE;
EUROPEAN UNION;
HUMANS;
PSYCHOTROPIC DRUGS;
QUALITY ASSURANCE, HEALTH CARE;
TREATMENT OUTCOME;
|
|
EID: 33845765623
PISSN: 00333158
EISSN: None
Source Type: Journal
DOI: 10.1007/s00213-006-0629-3 Document Type: Note |
|
Times cited : (9)
|
|
References (5)
|
